You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

Advanta V12

Atrium ADVANTA V12 Balloon Expandable Covered Stent

Advanta V12

Balloon expandable covered stent

Trusted. Reliable. Proven.

Now Available in Large Diameter

Increasing your treatment options with 12 mm diameter balloon expandable covered stents.

Learn more about Advanta V12 balloon expandable covered stent in larger size


Conformable, deliverable, flexible

Designed to track through tortuous arteries and flex to accommodate the iliac and renal anatomy

Low Profile

6Fr & 7Fr compatibility offers versatility and efficient delivery in complex endovascular procedures 
9Fr compatibility for large diameter stents offers more options for percutaneous interventions

Ability to post-dilate

Allows a customized solution to various anatomy*

*Post dilation should always be performed following the guidelines within the Advanta V12 covered stent IFU.

Long-term positive outcomes of Getinge Advanta V12 stand out in new systematic literature review

The reliable outcomes of Getinge’s Advanta V12 has been confirmed again by a new systematic literature review. A group of physicians from around the world joined to compare published studies of covered balloon expandable (CBE) stents for aorto-iliac occlusive disease (AIOD) – and the Advanta V12/iCast device stands out as the only solution with most real world, long term data.

Click here to read more

Cobest study patency graph

COBEST - Randomized Multicenter Study Advanta V12 vs Bare Metal Stents

5-Year Data
  • Two-fold lower incidence of re-intervention (p=.02)
  • Significantly higher patency rates at 5 years (74.7% vs. 62.9%; p=.01)[1]
  • Significantly higher patency in subgroup analysis of TASC C/D lesions (p=.003) [1]


All references

  1. Mwipatayi BP, Sharma S, Daneshmand A, et al. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2016. Jul;64(1):83-94.

  2. Laird JR, Loja M, Zeller T, et al. iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study. J Vasc Interv Radiol. 2019 Jun;30(6)